聚乙二醇化聚十六烷基氰基丙烯酸酯的合成及其作为纳米药物载体的应用研究-中国药房

聚乙二醇化聚十六烷基氰基丙烯酸酯的合成及其作为纳米药物载体的应用研究

请在关注微信后，向客服人员索取文件

篇名：	聚乙二醇化聚十六烷基氰基丙烯酸酯的合成及其作为纳米药物载体的应用研究
TITLE：
摘要：	目的：合成有机聚合物聚乙二醇化聚十六烷基氰基丙烯酸酯（mPEG-PHDCA），制备载药mPEG-PHDCA纳米粒，并研究其体外释药行为。方法：采用Knoevenagel反应和阴离子聚合反应合成mPEG-PHDCA，通过核磁共振氢谱（1H-NMR）进行表征，凝胶渗透色谱（GPC）法测定重均分子量和多分散系数（PDI）。以阿霉素为模型药，采用复乳-溶剂挥发法制备载阿霉素的mPEG-PHDCA纳米粒，透射电镜观察其微观形貌，粒径仪测定其粒径和Zeta电位。高效液相色谱法测定纳米粒中阿霉素的含量并计算载药量和包封率，透析袋法考察其体外释药特性，比较其与阿霉素溶液的体外释药效果。结果：经过1H-NMR和GPC表征，成功合成mPEG-PHDCA，重均分子量约为6 000，PDI为1.13。所制载阿霉素的mPEG-PHDCA纳米粒呈圆球颗粒状，表面光滑、大小均匀、分布良好，无团聚现象，粒径、Zeta电位、载药量和包封率分别为（94.61±3.91） nm、（－11.68±0.83） mV、（2.17±0.67）％、（79.54±4.66）％（n＝3）。载阿霉素的mPEG-PHDCA纳米粒48 h的体外累积释药率达到85.38％，释药曲线符合Weibull方程（R2＝0.979 4）；阿霉素溶液体外4 h已基本释药完全。结论：成功合成具有良好载药性能、生物相容性和缓释特性的mPEG-PHDCA，其有望成为新型纳米递药载体。
ABSTRACT：	OBJECTIVE： To synthesize Monomethoxy-polyethyleneglycolcyanoacrylate-co-poly-hexadecylcyanoacrylate （mPEG- PHDCA）， prepare adriamycin-loaded mPEG-PHDCA nanoparticle and study its in vitro drug release behavior. METHODS： Knoevenagel reaction and anionic polymerization were adopted to synthesize mPEG-PHDCA， and it was characterized with 1H-NMR. Weight-average molecular weight and polydispersity index （PDI） were determined by gel permeation chromatography （GPC）. Using adriamycin as model drug， complex emulsion-solvent evaporation method was used to prepare adriamycin-loaded mPEG-PHDCA nanoparticle. TEM was adopted to observe its micromorphology； particle size and Zeta potential were determined by particle size instrument. The content of adriamycin， drug-loading amount and encapsulated efficiency in nanoparticle were determined by HPLC. The characteristics of drug release in vitro were investigated by dialysis bag method. The drug release in vitro of it was compared with that of adriamycin. RESULTS： After characterized with 1H-NMR and GPC， mPEG-PHDCA was synthesized successfully； mass average molar mass was about 6 000， and PDI was 1.13. Prepared adriamycin-loaded mPEG-PHDCA nanoparticle was round ball-like granule and had smooth appearance， uniform size and good distribution without agglomeration. Particle size， Zeta-potential， drug-loading amount and entrapment efficiency were （94.61±3.91） nm，（－11.68±0.83） mV，（2.17±0.67）％，（79.54±4.66）％（n＝3）. Accumulative release rate of adriamycin-loaded mPEG-PHDCA nanoparticle reached 85.38％ within 48 h. Drug release curve was Weibull equation distribution （R2＝0.979 4）. The adriamycin solution was released completely in vitro after 4 h. CONCLUSIONS： mPEG-PHDCA is synthesized with good drug loading efficiency， biocompatibility and sustained-release properties. It is expected to be a new nano drug delivery carrier.
期刊：	2018年第29卷第13期
作者：	王丛瑶，沈利君，孔毅，翁建华，叶晓莉
AUTHORS：	WANG Congyao，SHEN Lijun，KONG Yi，WENG Jianhua，YE Xiaoli
关键字：	聚乙二醇化聚十六烷基氰基丙烯酸酯；纳米粒；缓释特性；阿霉素
KEYWORDS：	mPEG-PHDCA； Nanoparticles； Sustained-release characteristics； Adriamycin
阅读数：	303 次
本月下载数：	7 次

* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！